Arya Amini

Trials

Studies that name Arya Amini as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:54 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07926906 · Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma

  City of Hope Medical Center · not yet recruiting · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · principal investigator
• N/A
  NCT07225855 · Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

  City of Hope Medical Center · recruiting · Localized Head and Neck Carcinoma · principal investigator
• N/A
  NCT06139627 · Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

  City of Hope Medical Center · recruiting · Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT06014827 · Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

  City of Hope Medical Center · recruiting · Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT05840770 · Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

  City of Hope Medical Center · withdrawn · Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT05830058 · Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

  City of Hope Medical Center · recruiting · Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma · principal investigator
• Ph1
  NCT05085496 · Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

  City of Hope Medical Center · active not recruiting · Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma · principal investigator
• N/A
  NCT03902535 · Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers

  City of Hope Medical Center · completed · Caregiver, Head and Neck Carcinoma, Lung Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT07926906, NCT07225855, NCT06139627, NCT06014827, NCT05840770, NCT05830058, NCT05085496, NCT03902535